AEON Biopharma Inc.

NASDAQ: AEON · Real-Time Price · USD
0.80
0.02 (2.56%)
At close: Aug 15, 2025, 3:59 PM
0.80
-0.62%
After-hours: Aug 15, 2025, 07:50 PM EDT

AEON Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
72.98M n/a -48.43M -65.85M
Interest Income
n/a n/a n/a n/a
Pretax Income
42.01M n/a -52.56M -55.64M
Net Income
42.01M n/a -52.56M -55.64M
Selling & General & Admin
13.64M n/a 13.68M 11.15M
Research & Development
14.18M n/a 34.75M 25.73M
Other Expenses
-100.81M n/a n/a 28.97M
Operating Expenses
-72.98M n/a 48.43M 65.85M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-72.98M n/a 48.43M 65.85M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
7.5K 516.11K 305.5K 305.5K
Shares Outstanding (Diluted)
8K 516.11K 305.5K 305.5K
EPS (Basic)
5.6K n/a -172.03 -182.12
EPS (Diluted)
5.25K n/a -172.03 -182.12
EBITDA
-27.73M n/a -48.36M -36.88M
EBIT
-27.82M n/a -48.43M -36.88M
Depreciation & Amortization
97K n/a 68K 3K